Analyse
Analyses approfondies des marchés pharmaceutiques, des chaînes d'approvisionnement, de la technologie et de la réglementation
Analyse
12 sept. 2026•1 min de lecture
Co‑promotion contracts end for major drugs, prompting distribution shift in Korea
Major co‑promotion agreements with Jongkundang are ending, shifting supply to sole distributors and other pharma firms, prompting pharmacies to tighten inventory controls.
Analyse
11 sept. 2026•1 min de lecture
JW중외제약, ‘프렌즈’ 인공눈물 브랜드를 식품으로 확장… ‘아이크런치’ 캔디 출시
JW중외제약이 인공눈물 ‘프렌즈’ 브랜드를 식품 영역으로 확대해 씹는 캔디 ‘아이크런치’를 출시했습니다.
Analyse
11 sept. 2026•1 min de lecture
SkyLabs partners with IEM GmbH to launch ring‑type blood pressure monitor in Europe
SkyLabs and German ABPM specialist IEM GmbH signed a supply deal to bring the ring‑type CART blood pressure monitor to UK and European hospitals, targeting 26 billion KRW sales in early 2026.
Analyse
11 sept. 2026•1 min de lecture
Samsung Biologics Announces 3 trillion KRW Capital Increase to Fund Expansion
Samsung Biologics raised ~3 trillion KRW via a rights issue and public offering, issuing 2.27 million new shares (4.9% of existing). Funds will support PolyPeptide acquisition, Plant 6, a third bio‑campus and US facilities.
Analyse
10 sept. 2026•1 min de lecture
Korean Health Functional Food Association Hosts Overseas Buyer Counseling at K-Health Conference 2026
The association organized a counseling session with 25 member firms and five overseas buyers from the US, Vietnam, Indonesia, Taiwan and Poland to boost export opportunities.
Analyse
10 sept. 2026•1 min de lecture
Pharmacy Prescription Compounding and OTC Sales Drop in Week 34, 2026
Average prescription compounding fell 12% YoY and OTC sales fell 12.5% YoY, with throat treatments seeing the steepest decline.
Analyse
9 sept. 2026•1 min de lecture
Boryeong launches "Malkuncho Kids Syrup" to enter 10 billion KRW children's digestive OTC market
Boryeong Consumer Healthcare rolls out "Malkuncho Kids Syrup" aiming at Korea's ~10 billion KRW children’s digestive and antacid market, where GC녹십자 holds ~70% share.
Analyse
9 sept. 2026•1 min de lecture
Il-yang Pharmaceutical Launches Gigaen, a Bronchial Health Supplement
Il-yang Pharmaceutical introduced Gigaen, a health functional food containing MFDS‑approved gamguk‑gamtae extract, aimed at supporting bronchial health and relieving cough and phlegm.
Analyse
9 sept. 2026•1 min de lecture
Daewon Pharmaceutical Continues Production and Supply of Cough Expectorant ‘Kodaewon‑Jeong’
Daewon Pharmaceutical announced it will keep producing and distributing its cough expectorant ‘Kodaewon‑Jeong’ without any supply interruption, citing patient convenience and prescription clarity.
Analyse
9 sept. 2026•1 min de lecture
Nestlé Health Science launches GLP‑1 nutrition platform
Nestlé Health Science introduces a GLP‑1 nutrition platform covering muscle, gut, micronutrients, hydration, skin/hair health and weight‑regain management as GLP‑1 obesity drugs spread.
Analyse
8 sept. 2026•1 min de lecture
Dongkook Pharmaceutical Launches TECA Plus Formula Facial Repair Cream Light
Dongkook Pharmaceutical’s dermal repair brand Madecaphamacia introduced the TECA Plus Formula Facial Repair Cream Light, featuring enhanced moisture, absorption, and added PDRN, available in ~6,000 Korean pharmacies.
Analyse
8 sept. 2026•1 min de lecture
Healthcare Platform GeoYoung Conducts Joint Fire Safety Inspection and Training in Incheon
GeoYoung held a joint on‑site inspection and fire‑adaptation drill with Incheon Gyeyang Fire Station to assess fire risks in large logistics warehouses.